Clinical Research Certification (SOCRA CCRP) – Exam Prep 95 Questions | IRB Regulations, Informed Consent, IND Studies, GCP Ethics | Society of Clinical Research Associates 2026

This document contains 95 SOCRA certification exam questions with verified answers designed to help candidates prepare for the Certified Clinical Research Professional (CCRP) examination administered by the Society of Clinical Research Associates (SOCRA). The material is organized in a structured question-and-answer format covering key regulatory, ethical, and operational concepts required for professionals involved in clinical research and clinical trial management. The study guide aligns closely with regulatory and ethical frameworks commonly taught in clinical research training programs, including ICH Good Clinical Practice (GCP) guidelines, FDA regulations, and human subjects protection standards. It reviews essential regulatory concepts such as electronic records and electronic signatures compliance, which the FDA recognizes as legally equivalent to handwritten records when systems meet regulatory requirements and are properly validated. A significant portion of the document focuses on clinical trial oversight and regulatory compliance. Topics include Institutional Review Board (IRB) structure, IRB approval requirements, expedited review processes, and responsibilities related to continuing review of research protocols. For example, IRBs must include at least five members with diverse backgrounds, including scientific and nonscientific members, to ensure adequate ethical and scientific evaluation of proposed studies. The material also provides extensive coverage of informed consent requirements for human subjects research. Key elements of informed consent include explanation of the research purpose, disclosure of risks and benefits, available alternatives, confidentiality protections, and voluntary participation statements. The document emphasizes that informed consent cannot include exculpatory language that waives a participant’s legal rights. Another major topic is clinical trial design and investigational drug development. The guide reviews the three phases of investigational drug trials: Phase I: Initial human testing to evaluate pharmacokinetics and safety (typically 20–80 subjects) Phase II: Controlled studies assessing effectiveness and short-term side effects (several hundred subjects) Phase III: Large-scale trials evaluating safety and overall benefit-risk ratio in broader populations These sections help candidates understand the regulatory pathway required before investigational drugs can receive marketing approval. The document also addresses Investigational New Drug (IND) applications, including requirements for submission, clinical holds, investigator responsibilities, and reporting obligations to the FDA. For example, investigators may begin clinical trials 30 days after submitting an IND unless the FDA issues a clinical hold due to safety concerns or incomplete documentation. Another critical area covered is safety monitoring and adverse event reporting. The material explains the distinction between adverse events (AEs) and serious adverse events (SAEs), noting that SAEs include outcomes such as death, life-threatening conditions, hospitalization, disability, or congenital defects. The document also describes timelines for expedited reporting of serious and unexpected adverse drug reactions. Ethical frameworks governing human subjects research are also examined, including major historical guidelines such as the Nuremberg Code, Declaration of Helsinki, and the Belmont Report. The Belmont Report’s three core ethical principles—Respect for Persons, Beneficence, and Justice—are discussed as foundational principles guiding modern clinical research ethics. The guide further explores protections for vulnerable populations, including children, prisoners, pregnant women, and neonates participating in research. Special consent requirements, assent procedures, and additional IRB safeguards are required when studies involve these populations. Courses where this document may be relevant include: Clinical Research Methods Clinical Trials Management Good Clinical Practice (GCP) Training Regulatory Affairs in Clinical Research Human Subjects Research Ethics Students and professionals who may benefit from this document include: Candidates preparing for the SOCRA Certified Clinical Research Professional (CCRP) exam Clinical research coordinators (CRCs) Clinical research associates (CRAs) Regulatory affairs specialists Medical research professionals involved in clinical trials Overall, this document functions as a comprehensive SOCRA CCRP exam preparation resource, covering FDA regulations, clinical trial phases, ethical research standards, informed consent procedures, safety reporting requirements, and IRB governance necessary for successful clinical research practice. Keywords SOCRA CCRP certification exam questions clinical research professional certification study guide good clinical practice GCP guidelines clinical trials investigational new drug IND application regulations institutional review board IRB research compliance informed consent elements clinical research ethics clinical trial phase 1 phase 2 phase 3 studies adverse event serious adverse event reporting FDA belmont report nuremberg code declaration helsinki clinical research coordinator regulatory compliance